These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 16893402)

  • 1. Anemia management in chronic kidney disease: what have we learned after 17 years?
    Spiegel DM
    Semin Dial; 2006; 19(4):269-72. PubMed ID: 16893402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should the target hemoglobin for patients with chronic kidney disease treated with erythropoietic replacement therapy be changed?
    Berns JS
    Semin Dial; 2005; 18(1):22-9. PubMed ID: 15663760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on erythropoietin treatment: should hemoglobin be normalized in patients with chronic kidney disease?
    Paoletti E; Cannella G
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S74-7. PubMed ID: 16565252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Target hemoglobin level for EPO therapy in CKD.
    Parfrey PS
    Am J Kidney Dis; 2006 Jan; 47(1):171-3. PubMed ID: 16377399
    [No Abstract]   [Full Text] [Related]  

  • 5. The optimal hemoglobin in dialysis patients- a critical review.
    Singh AK; Fishbane S
    Semin Dial; 2008; 21(1):1-6. PubMed ID: 18251947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Should anemia be completely corrected in patients with chronic renal failure?].
    Kes P; Brunetta B
    Lijec Vjesn; 2002; 124(6-7):225-7. PubMed ID: 19658341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is needed to achieve a hemoglobin of 11.0-13.0 g/dl in end-stage renal disease.
    Fishbane S
    Blood Purif; 2007; 25(1):53-7. PubMed ID: 17170538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Spanish survey on anaemia management].
    Pérez García R
    Nefrologia; 2003; 23(4):300-11. PubMed ID: 14558329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of an anemia clinic on emergency room visits and hospitalizations in patients with anemia of CKD pre-dialysis.
    Perkins R; Olson S; Hansen J; Lee J; Stiles K; Lebrun C
    Nephrol Nurs J; 2007; 34(2):167-73, 182. PubMed ID: 17486947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anemia management in chronic kidney disease.
    Gillespie BS; Inrig JK; Szczech LA
    Hemodial Int; 2007 Jan; 11(1):15-20. PubMed ID: 17257350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemoglobin normalization trials in chronic kidney disease: what should we learn about quality of life as an end point?
    Covic A; Seica A; Gusbeth-Tatomir P; Goldsmith D
    J Nephrol; 2008; 21(4):478-84. PubMed ID: 18651536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Once-monthly subcutaneous C.E.R.A. maintains stable hemoglobin control in patients with chronic kidney disease on dialysis and converted directly from epoetin one to three times weekly.
    Sulowicz W; Locatelli F; Ryckelynck JP; Balla J; Csiky B; Harris K; Ehrhard P; Beyer U;
    Clin J Am Soc Nephrol; 2007 Jul; 2(4):637-46. PubMed ID: 17699476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Regarding the optimal hemoglobin target range in renal anemia].
    Maurin N
    Med Klin (Munich); 2008 Sep; 103(9):633-7. PubMed ID: 18813886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Target level for hemoglobin correction in patients with diabetes and CKD: primary results of the Anemia Correction in Diabetes (ACORD) Study.
    Ritz E; Laville M; Bilous RW; O'Donoghue D; Scherhag A; Burger U; de Alvaro F;
    Am J Kidney Dis; 2007 Feb; 49(2):194-207. PubMed ID: 17261422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction between heart failure and other heart diseases, renal failure, and anemia.
    Silverberg DS; Wexler D; Iaina A; Schwartz D
    Semin Nephrol; 2006 Jul; 26(4):296-306. PubMed ID: 16949468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the therapeutic effects of epoetin zeta to epoetin alfa in the maintenance phase of renal anaemia treatment.
    Wizemann V; Rutkowski B; Baldamus C; Scigalla P; Koytchev R;
    Curr Med Res Opin; 2008 Mar; 24(3):625-37. PubMed ID: 18208642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction towards normal hemoglobin values in chronic kidney disease: what is the current evidence regarding mortality and morbidity outcomes?
    Scherhag A
    Kidney Blood Press Res; 2009; 32(1):1-10. PubMed ID: 19155636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of erythropoietin in anemia after heart transplantation.
    Gleissner CA; Klingenberg R; Staritz P; Koch A; Ehlermann P; Wiggenhauser A; Dengler TJ
    Int J Cardiol; 2006 Oct; 112(3):341-7. PubMed ID: 16309765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [What are the aims and targets of renal anemia therapy?].
    Eckardt KU
    Dtsch Med Wochenschr; 2007 Sep; 132(36):1837-41. PubMed ID: 17726657
    [No Abstract]   [Full Text] [Related]  

  • 20. Iron supplementation in renal anemia.
    Fishbane S
    Semin Nephrol; 2006 Jul; 26(4):319-24. PubMed ID: 16949471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.